Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment (Q40529135)

From Wikidata

Jump to navigation Jump to search

scientific article published on 23 September 2016

Language	Label	Description	Also known as
English	Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment	scientific article published on 23 September 2016

Statements

scholarly article

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/PMC/5464320

Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment (English)

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/PMC/5464320

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Evanthia Galanis

10

object named as

Evanthia Galanis

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/PMC/5464320

author name string

Jayson Hardcastle

1

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/PMC/5464320

Lisa Mills

2

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/PMC/5464320

Courtney S Malo

3

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/PMC/5464320

Fang Jin

4

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/PMC/5464320

Cheyne Kurokawa

5

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/PMC/5464320

Hirosha Geekiyanage

6

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/PMC/5464320

Mark Schroeder

7

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/PMC/5464320

Jann Sarkaria

8

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/PMC/5464320

Aaron J Johnson

9

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/PMC/5464320

publication date

1 April 2017

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/PMC/5464320

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/PMC/5464320

19

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/PMC/5464320

4

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/PMC/5464320

493-502

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/PMC/5464320

PD-L1 expression and prognostic impact in glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Emerging therapies for glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Medical management of high-grade astrocytoma: current and emerging therapies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Oncolytic viruses as therapeutic cancer vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Microglia and macrophages in malignant gliomas: recent discoveries and implications for promising therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

EGRF conjugated PEGylated nanographene oxide for targeted chemotherapy and photothermal therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

HMGB1 in cancer: good, bad, or both?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Origin and differentiation of microglia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Oncolytic measles virus strains have significant antitumor activity against glioma stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Effective radiovirotherapy for malignant gliomas by using oncolytic measles virus strains encoding the sodium iodide symporter (MV-NIS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Measles virus causes immunogenic cell death in human melanoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Adherens junction protein nectin-4 is the epithelial receptor for measles virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Establishment, maintenance and in vitro and in vivo applications of primary human glioblastoma multiforme (GBM) xenograft models for translational biology studies and drug discovery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Nectin 4 overexpression in ovarian cancer tissues and serum: potential role as a serum biomarker

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Synergistic anti-tumor effects between oncolytic vaccinia virus and paclitaxel are mediated by the IFN response and HMGB1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Immunological factors relating to the antitumor effect of temozolomide chemoimmunotherapy in a murine glioma model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

HMGB1 mediates endogenous TLR2 activation and brain tumor regression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

CD46 represents a target for adenoviral gene therapy of malignant glioma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Nectin-4, a new serological breast cancer marker, is a substrate for tumor necrosis factor-alpha-converting enzyme (TACE)/ADAM-17.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Measles virus V protein blocks interferon (IFN)-alpha/beta but not IFN-gamma signaling by inhibiting STAT1 and STAT2 phosphorylation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Restriction of measles virus RNA synthesis by a mouse host cell line: trans-complementation by polymerase components or a human cellular factor(s)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

SLAM (CDw150) is a cellular receptor for measles virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

The human CD46 molecule is a receptor for measles virus (Edmonston strain)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Cytotoxic cells in immunodeficient athymic mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

17 June 2018

Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

17 June 2018

CTLA-4 and PD-L1 checkpoint blockade enhances oncolytic measles virus therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

17 June 2018

Glioma virus therapies between bench and bedside

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

17 June 2018

A comparative review of cell culture systems for the study of microglial biology in Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

17 June 2018

Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR- or EGFRvIII expressing gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

17 June 2018

CD46 expression does not overcome the intracellular block of measles virus replication in transgenic rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

17 June 2018

Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

20 August 2018

Measles virus induces oncolysis of mesothelioma cells and allows dendritic cells to cross-prime tumor-specific CD8 response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

20 August 2018

Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

20 August 2018

Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

20 August 2018

In vivo magnetic resonance imaging of immune cells in the central nervous system with superparamagnetic antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/27663389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/NEUONC/NOW179

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/PMC/5464320

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/PMC/5464320

1 reference

Europe PubMed Central

21 May 2018

http://europepmc.org/abstract/PMC/5464320

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40529135&oldid=1900011865"